Arcutis Biotherapeutics

-$0.62 (-2.48%) As of 7:02 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ARQT and other ETFs, options, and stocks.

About ARQT

Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its pipeline consists of topical treatments for plaque psoriasis, atopic dermatitis, hand eczema, vitiligo, scalp psoriasis, alopecia areata, and seborrheic dermatitis.

CEO
Todd Franklin Watanabe
Employees
54
Headquarters
Westlake Village, California
Founded
2016

ARQT Key Statistics

Market Cap
1.30B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
131.97K
High Today
$25.27
Low Today
$24.00
Open Price
$25.27
Volume
64.92K
52 Week High
$38.49
52 Week Low
$17.51

ARQT Earnings

-$1.15
-$0.77
-$0.38
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 10, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure